These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 2881797

  • 1. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N, Ahuja S, Diel F.
    Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
    [Abstract] [Full Text] [Related]

  • 2. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M, Välimäki M, Pelkonen R, Jansson R, Sivula A, Franssila K.
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [Abstract] [Full Text] [Related]

  • 3. Plasma and tumor levels of somatostatin (SRIF) and somatostatin immunochemistry in medullary thyroid carcinoma: apparently discrepant preliminary results.
    Franc B, Chayvialle JA, Modigliani E, Calmettes C, Caillou B, Dutrieux-Berger N, Houdent C, Kujas M.
    Henry Ford Hosp Med J; 1987 Nov; 35(2-3):147-8. PubMed ID: 2891647
    [No Abstract] [Full Text] [Related]

  • 4. [Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases].
    Charpin C, Argemi B, Cannoni M, Oliver C, Gillioz P, Vagneur JP, Toga M.
    Ann Pathol; 1984 Nov; 4(1):27-35. PubMed ID: 6142718
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunohistochemical hormone content in medullary and undifferentiated thyroid carcinoma and prognosis after surgery.
    Henninger S, Schatz H, Stracke H, Wagner U, Kracht J.
    Acta Histochem; 1988 Nov; 83(1):51-6. PubMed ID: 2897752
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Medullary carcinoma of the thyroid gland. Clinico-pathologic and immunohistochemical study].
    Elsner B, De Marco L, López S, Curutchet HP.
    Medicina (B Aires); 1983 Nov; 43(3):263-70. PubMed ID: 6369069
    [No Abstract] [Full Text] [Related]

  • 11. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B, Vagneur JP, Conforto C, Even F, Rollat MC, Simonin R.
    Bull Cancer; 1984 Nov; 71(2):133-9. PubMed ID: 6733293
    [Abstract] [Full Text] [Related]

  • 12. Immunoreactive gastrin-releasing peptide in medullary thyroid carcinoma.
    Modigliani E, Casanova S, Chayvialle JA, Bernard C, Franc B, Cohen R, Calmettes C.
    J Clin Endocrinol Metab; 1990 Oct; 71(4):831-5. PubMed ID: 1976126
    [Abstract] [Full Text] [Related]

  • 13. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
    Talerman A, Lindeman J, Kievit-Tyson PA, Dröge-Droppert C.
    Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Immunohistochemical and serological demonstration of thyreoglobulin tissue polypeptide antigen, carcinoembryonic antigen and calcitonin in diversely differentiated thyroid gland carcinomas and thyroid gland adenomas].
    Vogel J, Oehr P, Grouls V.
    Pathologe; 1985 May; 6(3):133-40. PubMed ID: 3892526
    [No Abstract] [Full Text] [Related]

  • 17. Surgical treatment of medullary carcinoma of the thyroid.
    Block MA.
    Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
    [Abstract] [Full Text] [Related]

  • 18. Coexistence of somatostatin-immunoreactivity in an adrenal pheochromocytoma and a thyroid medullary carcinoma (Sipple syndrome).
    Bethge N, Ahuja S, Diel F, Usadel KH.
    Exp Clin Endocrinol; 1988 May; 91(2):217-22. PubMed ID: 2900771
    [Abstract] [Full Text] [Related]

  • 19. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
    Miyauchi A, Onishi T, Matsuzuka F, Hirai K, Kuma K, Takai S, Nakamoto K, Nakamura K, Nanjo S, Maeda M.
    Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
    [Abstract] [Full Text] [Related]

  • 20. Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma.
    Pfragner R, Höfler H, Behmel A, Ingolic E, Walser V.
    Cancer Res; 1990 Jul 01; 50(13):4160-6. PubMed ID: 1972348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.